Pharmacogenetics in cardiovascular disorders: An update on the principal drugs
In the coming years, genomics will impact clinical practice in multiple ways. However, one of the most important applications will be in the determination of the best treatments in personalized medicine. This is, in fact, one of the fields in which genetic variants have already been most successful...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
2013
|
| Online Access: | http://hdl.handle.net/20.500.11937/55833 |
| _version_ | 1848759718953091072 |
|---|---|
| author | Predazzi, I. Mango, R. Norata, Giuseppe Di Daniele, N. Sergi, D. Romeo, F. Novelli, G. |
| author_facet | Predazzi, I. Mango, R. Norata, Giuseppe Di Daniele, N. Sergi, D. Romeo, F. Novelli, G. |
| author_sort | Predazzi, I. |
| building | Curtin Institutional Repository |
| collection | Online Access |
| description | In the coming years, genomics will impact clinical practice in multiple ways. However, one of the most important applications will be in the determination of the best treatments in personalized medicine. This is, in fact, one of the fields in which genetic variants have already been most successful and useful to clinicians. Here, we briefly review the current state of the art on pharmacogenomics and its applications to modern cardiovascular medicine. © 2013 Springer International Publishing Switzerland. |
| first_indexed | 2025-11-14T10:04:21Z |
| format | Journal Article |
| id | curtin-20.500.11937-55833 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-14T10:04:21Z |
| publishDate | 2013 |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-558332017-09-13T16:10:39Z Pharmacogenetics in cardiovascular disorders: An update on the principal drugs Predazzi, I. Mango, R. Norata, Giuseppe Di Daniele, N. Sergi, D. Romeo, F. Novelli, G. In the coming years, genomics will impact clinical practice in multiple ways. However, one of the most important applications will be in the determination of the best treatments in personalized medicine. This is, in fact, one of the fields in which genetic variants have already been most successful and useful to clinicians. Here, we briefly review the current state of the art on pharmacogenomics and its applications to modern cardiovascular medicine. © 2013 Springer International Publishing Switzerland. 2013 Journal Article http://hdl.handle.net/20.500.11937/55833 10.1007/s40256-013-0020-9 restricted |
| spellingShingle | Predazzi, I. Mango, R. Norata, Giuseppe Di Daniele, N. Sergi, D. Romeo, F. Novelli, G. Pharmacogenetics in cardiovascular disorders: An update on the principal drugs |
| title | Pharmacogenetics in cardiovascular disorders: An update on the principal drugs |
| title_full | Pharmacogenetics in cardiovascular disorders: An update on the principal drugs |
| title_fullStr | Pharmacogenetics in cardiovascular disorders: An update on the principal drugs |
| title_full_unstemmed | Pharmacogenetics in cardiovascular disorders: An update on the principal drugs |
| title_short | Pharmacogenetics in cardiovascular disorders: An update on the principal drugs |
| title_sort | pharmacogenetics in cardiovascular disorders: an update on the principal drugs |
| url | http://hdl.handle.net/20.500.11937/55833 |